Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials.
J Eur Acad Dermatol Venereol
; 27(5): 622-7, 2013 May.
Article
in En
| MEDLINE
| ID: mdl-22404103
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Cardiovascular Diseases
/
Randomized Controlled Trials as Topic
/
Interleukin-12
/
Interleukin-23
/
Antibodies
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2013
Document type:
Article
Affiliation country:
Germany